Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in COVID-19 Patients Without Pneumonia
TCTR20200514001Phase 3Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Dec 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20200514001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200514001.